These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22753686)

  • 1. Update in diffuse parenchymal lung disease 2011.
    Luckhardt TR; Müller-Quernheim J; Thannickal VJ
    Am J Respir Crit Care Med; 2012 Jul; 186(1):24-9. PubMed ID: 22753686
    [No Abstract]   [Full Text] [Related]  

  • 2. Update in Interstitial Lung Disease 2014.
    Belloli EA; Martinez FJ; Flaherty KR
    Am J Respir Crit Care Med; 2015 Sep; 192(5):538-43. PubMed ID: 26561676
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic Approach to Adult Fibrotic Lung Diseases.
    Adegunsoye A; Strek ME
    Chest; 2016 Dec; 150(6):1371-1386. PubMed ID: 27521738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of fibrosing diffuse parenchymal lung disease.
    Morgenthau AS; Padilla ML
    Mt Sinai J Med; 2009 Feb; 76(1):2-23. PubMed ID: 19170214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update in diffuse parenchymal lung diseases 2005.
    Martinez FJ; Keane MP
    Am J Respir Crit Care Med; 2006 May; 173(10):1066-71. PubMed ID: 16679445
    [No Abstract]   [Full Text] [Related]  

  • 6. Update in diffuse parenchymal lung disease, 2013.
    Rosas IO; Kaminski N
    Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult interstitial lung diseases and their epidemiology.
    Sesé L; Khamis W; Jeny F; Uzunhan Y; Duchemann B; Valeyre D; Annesi-Maesano I; Nunes H
    Presse Med; 2020 Jun; 49(2):104023. PubMed ID: 32437842
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolving pharmacotherapy of pulmonary fibrosis.
    Lota HK; Wells AU
    Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment in diffuse interstitial lung diseases].
    Kayacan O
    Tuberk Toraks; 2005; 53(2):190-9. PubMed ID: 16100659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?
    Heron M; Claessen AM; Grutters JC; van den Bosch JM
    Clin Exp Immunol; 2010 May; 160(2):256-65. PubMed ID: 20030671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirfenidone induced phototoxic reaction in an elderly man.
    Gaikwad RP; Mukherjee SS
    Indian J Dermatol Venereol Leprol; 2016; 82(1):101-3. PubMed ID: 26728829
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of pirfenidone on renal function in patients with interstitial pneumonia.
    Matsumoto J; Sunohara K; Mori Y; Nagaya H; Inaba S
    Ren Fail; 2021 Dec; 43(1):879-881. PubMed ID: 34018462
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of bronchoalveolar lavage in diffuse parenchymal lung diseases.
    Kilinç G; Kolsuk EA
    Curr Opin Pulm Med; 2005 Sep; 11(5):417-21. PubMed ID: 16093816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New frontiers for rare pulmonary diseases.
    Agostini C; Harari S
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S1-3. PubMed ID: 16457010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.
    Vasakova M; Morell F; Walsh S; Leslie K; Raghu G
    Am J Respir Crit Care Med; 2017 Sep; 196(6):680-689. PubMed ID: 28598197
    [No Abstract]   [Full Text] [Related]  

  • 17. Interstitial lung disease and gastroesophageal reflux.
    Ing AJ
    Am J Med; 2001 Dec; 111 Suppl 8A():41S-44S. PubMed ID: 11749923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung.
    Lakari E; Soini Y; Säily M; Koistinen P; Pääkkö P; Kinnula VL
    Am J Clin Pathol; 2002 Jan; 117(1):132-42. PubMed ID: 11789718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 76-year-old woman with polymyalgia, polyarthralgia, and interstitial lung disease.
    Puruckherr M; Gupta K; Youngberg G; Krishnaswamy G; Roy T
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):113-6. PubMed ID: 11529256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.